Article
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis.
Journal of viral hepatitis - 1 Oct 2017
Vukotic R, Conti F, Fagiuoli S, Morelli M C, Pasulo L, Colpani M, Foschi F G, Berardi S, Pianta P, Mangano M, Donato M F, Malinverno F, Monico S, Tamè M, Mazzella G, Belli L S, Viganò R, Carrai P, Burra P, Russo F P, Lenci I, Toniutto P, Merli M, Loiacono L, Iemmolo R, Degli Antoni A M, Romano A, Picciotto A, Rendina M, Andreone P
Abstract excerpt
Long-term functional outcomes of sofosbuvir-based antiviral treatment were evaluated in a cohort study involving 16 Italian centres within the international compassionate use programme for post-transplant hepatitis C virus (HCV) recurrence. Seventy-three patients with cirrhosis (n=52) or fibrosing cholestatic hepatitis (FCH, n=21) received 24-week sofosbuvir with ribavirin±pegylated interferon or interferon-free...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.